Vice President, Advisory Services
Brad Smith, vice president, leads the transnational medicine advisory services within Quintiles. In this position, Dr. Smith leads biomarker and companion diagnostic strategy and planning interactions throughout the organization including clinical, laboratory, consulting and commercial projects.
Dr. Smith has more than 20 years of experience in biological research in academia, biotechnology and clinical services including five years of experience in planning and design of clinical development plans and protocols for drug development. Prior to Quintiles, Smith spent 10 years at Cell Signaling Technology responsible for technical and corporate development of biomarker and diagnostic businesses. He is the author of multiple basic research, translational medicine and clinical publications and patents.
Dr. Smith’s scientific background includes research positions at Stanford University and University of California, San Francisco focused on cellular signaling mechanisms of disease. He holds a Doctoral degree from Stanford University and Master’s and Bachelor’s degrees from University of California, Santa Cruz.